Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.10.2 (
focal adhesion kinase
)
44,029
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
JAK2
activation is crucial for cytokine receptor signal transduction and leukemogenesis. However, the underlying processes that lead to full activation of
JAK2
are unclear. Here, we report a positive role for ubiquitination of
JAK2
during GM-CSF-induced activation. Upon GM-CSF stimulation,
JAK2
ubiquitination is significantly enhanced through K63-linked poly-ubiquitination. Studies employing both knockout and overexpression of Cbl, an E3 ubiquitin ligase, led to the conclusion that Cbl specifically promotes
JAK2
ubiquitination, and this was further confirmed in vitro using a Cbl ubiquitination assay. Moreover, following GM-CSF stimulation, the levels of phospho-
JAK2
and -STAT5 and a STAT5 luciferase reporter assay were all reduced in Cbl knockout cells and this effect could be rescued by Cbl expression. Mechanistically, Cbl can interact with, and ubiquitinate
JAK2
FERM and kinase domains via the Cbl
TKB
domain. Using lysine-to-arginine site-directed mutagenesis, K970 in the kinase domain of
JAK2
was identified as the ubiquitination site important for promoting full
JAK2
activation by Cbl via K63-conjugated poly-ubiquitination. Our study suggests that GM-CSF-induced
JAK2
activation is enhanced by Cbl-mediated ubiquitination of
JAK2
. Targeting ubiquitination of
JAK2
might offer a novel therapeutic strategy against
JAK2
-mediated disorders.
...
PMID:Cbl-mediated K63-linked ubiquitination of JAK2 enhances JAK2 phosphorylation and signal transduction. 2867 38